91 related articles for article (PubMed ID: 21913909)
1. Treatment with tocilizumab leads to the disappearance of olecranon rheumatoid nodules.
Al Attia HM; Abushawish M
Int J Dermatol; 2012 Feb; 51(2):197-8. PubMed ID: 21913909
[No Abstract] [Full Text] [Related]
2. Marked improvement of lung rheumatoid nodules after treatment with tocilizumab.
Andres M; Vela P; Romera C
Rheumatology (Oxford); 2012 Jun; 51(6):1132-4. PubMed ID: 22328566
[No Abstract] [Full Text] [Related]
3. Isolated Rheumatoid Nodule of the Achilles.
Spicer PJ; Broussard G; Beaman F
Ultrasound Q; 2016 Jun; 32(2):187-90. PubMed ID: 26086458
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry).
Glace B; Gottenberg JE; Mariette X; Philippe R; Pereira B; Lequerré T; Berthelot JM; Dougados M; Toussirot E; Pham T; Allanore Y; Loeuille D; Euller-Ziegler L; Soubrier M
Ann Rheum Dis; 2012 Aug; 71(8):1429-31. PubMed ID: 22504557
[No Abstract] [Full Text] [Related]
5. A case of bilateral rheumatoid pleuritis successfully treated with tocilizumab.
Ohtsuka K; Takeuchi K; Matsushita M; Aramaki T
Mod Rheumatol; 2014 Nov; 24(6):1001-4. PubMed ID: 24533552
[TBL] [Abstract][Full Text] [Related]
6. Tomographic regression of pulmonary rheumatoid nodules under baricitinib therapy.
Venerito V; Lopalco G; Anelli MG; Cacciapaglia F; Iannone F
Rheumatology (Oxford); 2019 Mar; 58(3):440. PubMed ID: 30212893
[No Abstract] [Full Text] [Related]
7. A case of overlap syndrome successfully treated with tocilizumab: a hopeful treatment strategy for refractory dermatomyositis?
Kondo M; Murakawa Y; Matsumura T; Matsumoto O; Taira M; Moriyama M; Sumita Y; Yamaguchi S
Rheumatology (Oxford); 2014 Oct; 53(10):1907-8. PubMed ID: 24859996
[No Abstract] [Full Text] [Related]
8. Subclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRI evaluation for 2 years.
Suzuki T; Hirota T; Ogishima H; Umeda N; Kondo Y; Yokosawa M; Miki H; Tsuboi H; Matsumoto I; Sumida T
Int J Rheum Dis; 2015 Jan; 18(1):108-10. PubMed ID: 25294091
[No Abstract] [Full Text] [Related]
9. Additional use of tacrolimus after switching to tocilizumab therapy in patients with primary lack of efficacy of infliximab therapy for rheumatoid arthritis.
Mori S
Mod Rheumatol; 2012 Nov; 22(6):947-50. PubMed ID: 22350573
[No Abstract] [Full Text] [Related]
10. Rheumatoid nodules and reflux disease.
Beaver ME; Stasney CR; Rodriguez M
Ear Nose Throat J; 2004 May; 83(5):309. PubMed ID: 15195871
[No Abstract] [Full Text] [Related]
11. Complete disappearance of pulmonary rheumatoid nodules after long term rituximab treatment: case report.
Frade-Sosa B; Azuaga AB; Ruiz-Esquide V; Gómez-Puerta JA; Sanmarti R
Rheumatol Int; 2023 Mar; 43(3):533-536. PubMed ID: 36318308
[TBL] [Abstract][Full Text] [Related]
12. Tocilizumab improves systemic rheumatoid vasculitis with necrotizing crescentic glomerulonephritis.
Iijima T; Suwabe T; Sumida K; Hayami N; Hiramatsu R; Hasegawa E; Yamanouchi M; Hoshino J; Sawa N; Takaichi K; Oohashi K; Fujii T; Ubara Y
Mod Rheumatol; 2015 Jan; 25(1):138-42. PubMed ID: 24533557
[TBL] [Abstract][Full Text] [Related]
13. Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks.
Yokoe I; Nishio S; Sato H; Kobayashi H
Mod Rheumatol; 2011 Dec; 21(6):710-4. PubMed ID: 21656090
[No Abstract] [Full Text] [Related]
14. A case report of a patient with rheumatoid arthritis complicated with Mycobacterium avium during tocilizumab treatment.
Nakahara H; Kamide Y; Hamano Y; Hosokawa T; Nishide M; Lin Y; Kawamoto K; Fusama M; Higa S; Kuroiwa T; Igarashi T; Kuritani T; Maeda K
Mod Rheumatol; 2011 Dec; 21(6):655-9. PubMed ID: 21484291
[TBL] [Abstract][Full Text] [Related]
15. Synovial fluid IL-6 concentrations associated with positive response to tocilizumab in an RA patient with failed response to anti-TNF and rituximab.
Wright HL; Mewar D; Bucknall RC; Edwards SW; Moots RJ
Rheumatology (Oxford); 2015 Apr; 54(4):743-4. PubMed ID: 25667432
[No Abstract] [Full Text] [Related]
16. Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study).
Mori S; Yoshitama T; Hidaka T; Hirakata N; Ueki Y
Ann Rheum Dis; 2015 Mar; 74(3):627-30. PubMed ID: 25561361
[No Abstract] [Full Text] [Related]
17. Tocilizumab in patients with active rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs or tumor necrosis factor inhibitors: subanalysis of Spanish results of an open-label study close to clinical practice.
Álvaro-Gracia JM; Fernández-Nebro A; García-López A; Guzmán M; Blanco FJ; Navarro FJ; Bustabad S; Armendáriz Y; Román-Ivorra JA;
Reumatol Clin; 2014; 10(2):94-100. PubMed ID: 24099961
[TBL] [Abstract][Full Text] [Related]
18. Successful use of tocilizumab in a patient with psoriatic arthritis.
Hughes M; Chinoy H
Rheumatology (Oxford); 2013 Sep; 52(9):1728-9. PubMed ID: 23424264
[No Abstract] [Full Text] [Related]
19. [Favorable response of pulmonary rheumatoid nodule to Rituximab].
Oqueka T; Schultz H; Moosig F
Z Rheumatol; 2009 Jun; 68(4):343-4. PubMed ID: 19330336
[TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor alpha independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules.
Baeten D; De Keyser F; Veys EM; Theate Y; Houssiau FA; Durez P
Ann Rheum Dis; 2004 May; 63(5):489-93. PubMed ID: 15082477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
